Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G - BridgeBio Oncology Therapeutics Inc. | StockGist | StockGist

Companies
BBOT
SCHEDULE 13G

Home Top Movers Companies Concepts

Home Filings BBOTSCHEDULE 13G

SCHEDULE 13G

Beneficial Ownership

BridgeBio Oncology Therapeutics Inc.

Filed Sep 3, 2025

Accepted Sep 2, 2025, 8:00 PM ET

CIK 0001869105

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

BridgeBio Oncology Therapeutics, Inc.

Person Type

PN

CUSIP: 107924102

Amendment History

5 filings

SCHEDULE 13G
Original
Viewing
Sep 3, 20250002013681-25-000001
SCHEDULE 13G/A
Amendment 1
Apr 22, 20250002052113-25-000396
SCHEDULE 13G/A
Amendment 2
Jul 30, 20250001104659-25-072172
SCHEDULE 13G/A
Amendment 3
Nov 13, 20250000902664-25-004881
SCHEDULE 13G/A
Amendment 4
Latest
Nov 14, 20250001104659-25-112512

Recent Filings

BridgeBio Oncology Therapeutics Inc.1 weeks ago

BridgeBio Oncology Therapeutics Inc.1 months ago

BridgeBio Oncology Therapeutics Inc.1 months ago

BridgeBio Oncology Therapeutics Inc.2 months ago

BridgeBio Oncology Therapeutics Inc.4 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice